District of Columbia § 48-831.09 Action with regard to nonparticipating manufacturers and labelers.

District of Columbia Statutes

§ 48-831.09 — Action with regard to nonparticipating manufacturers and labelers.

District of Columbia § 48-831.09

JurisdictionDistrict of Columbia

Title 48Foods and Drugs.

Ch. 8AAffordability of Prescription Drugs — AccessRx Program.

Subch. IAccessRx.

Part AGeneral.

This text of District of Columbia § 48-831.09 (Action with regard to nonparticipating manufacturers and labelers.) is published on Counsel Stack Legal Research, covering District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

D.C. Code § 48-831.09 (2026).

Text

(a)The names of manufacturers and labelers who do and do not enter into rebate agreements pursuant to this subchapter are public information. The Department shall release this information to health care providers and the public on a regular basis. The Department also shall publicize participation by manufacturers and labelers that is of particular benefit to the public.

(b)The Department shall impose prior authorization requirements, as permitted by law, in all publicly funded pharmaceutical assistance programs to the extent the Department determines it is appropriate to do so in order to encourage manufacturer and labeler participation in AccessRx, as long as the additional prior authorization requirements remain consistent with the goals of the D.C. Medicaid program and Title 19 of th

Free access — add to your briefcase to read the full text and ask questions with AI

(a) The names of manufacturers and labelers who do and do not enter into rebate agreements pursuant to this subchapter are public information. The Department shall release this information to health care providers and the public on a regular basis. The Department also shall publicize participation by manufacturers and labelers that is of particular benefit to the public.

(b) The Department shall impose prior authorization requirements, as permitted by law, in all publicly funded pharmaceutical assistance programs to the extent the Department determines it is appropriate to do so in order to encourage manufacturer and labeler participation in AccessRx, as long as the additional prior authorization requirements remain consistent with the goals of the D.C. Medicaid program and Title 19 of the Social Security Act, approved July 30, 1965 (79 Stat. 343; 42 U.S.C. § 1396 et seq.).